研究文章
潜在的风险因素是严重钝多发性创伤患者住院死亡率生存初始复苏
表5
并发症、器官衰竭和特定的干预措施在艾德承认和住院治疗。
|
|
幸存者
(n= 152,88
) |
Nonsurvivors
(n= 43岁的22
) |
所有的病人
(n= 195) |
p
|
|
| 并发症(n
) |
56 (37%) |
34 (79%) |
90例(46%) |
0.0001 |
| 肺炎 |
27 (18%) |
23 (53%) |
50 (26%) |
0.0001 |
| 脓毒症 |
18 (12%) |
17 (40%) |
35 (18%) |
0.0001 |
| 手术部位感染 |
18 (12%) |
12 (28%) |
30 (15%) |
0.012 |
| 骨科手术后 |
12 (8%) |
9 (21%) |
21 (11%) |
0.020 |
| 后腹部和/或泌尿生殖器的手术 |
6 (4%) |
3 (7%) |
9 (5%) |
0.315 |
| 尿路感染 |
14 (9%) |
8 (17%) |
22 (11%) |
0.079 |
| ARDS |
5 (3%) |
8 (19%) |
13 (7%) |
0.002 |
| 肺栓塞 |
4 (3%) |
3 (7%) |
7 (4%) |
0.182 |
| 筋膜室综合征 |
0 (0%) |
3 (7%) |
3 (2%) |
0.010 |
| 其他人 |
7 (5%) |
3 (8%) |
10 (5%) |
0.385 |
| 器官衰竭(n
) |
36 (24%) |
31 (72%) |
67例(34%) |
0.0001 |
| 呼吸 |
33 (22%) |
31 (72%) |
64例(33%) |
0.0001 |
| 心血管 |
21 (13%) |
31 (72%) |
52 (27%) |
0.0001 |
| 血液 |
7 (5%) |
26 (60%) |
33 (17%) |
0.0001 |
| 肝 |
12 (8%) |
19 (44%) |
31 (16%) |
0.0001 |
| 肾 |
3 (2%) |
24 (56%) |
27 (14%) |
0.0001 |
| Multiorgan(两个或两个以上的器官) |
27 (18%) |
31 (72%) |
58 (30%) |
0.0001 |
| 具体的干预措施(n
) |
|
|
|
|
| 机械通风 |
50 (28%) |
42 (95%) |
92例(43%) |
0.0001 |
| 无创通气 |
36 (24%) |
1 (2%) |
37 (20%) |
0.0001 |
| 管胸廓造口术 |
17 (11%) |
13 (30%) |
30 (15%) |
0.004 |
| 包装红细胞输血 |
69例(45%) |
42 (98%) |
111例(57%) |
0.0001 |
| 新鲜冷冻血浆输血 |
38 (25%) |
41 (95%) |
79例(41%) |
0.0001 |
| 血小板输血 |
18 (12%) |
26 (60) |
44 (23%) |
0.0001 |
| Antibiotherapy |
143例(94%) |
41 (95%) |
184例(94%) |
0.250 |
| 作用于血管的药物输液 |
33 (22%) |
37 (86%) |
70例(36%) |
0.0001 |
| 气管造口术 |
12 (8%) |
14 (33%) |
26 (13%) |
0.0001 |
| 肾脏替代治疗 |
2 (1%) |
11 (19%) |
13 (4%) |
0.0001 |
| 盆腔栓塞 |
2 (1%) |
3 (7%) |
5 (3%) |
0.072 |
|
|
ARDS:急性呼吸窘迫综合征;
p生存和nonsurviving团体之间的值比较; 例如,脑膜炎和脑部手术后颅内脓肿,癫痫,心律失常,缺氧脑损伤、尿崩症、褥疮、深静脉血栓形成。
|
